The three private equity consortiums bidding for Dutch chemicals company Akzo Nobel's €10bn ($12.9bn) pharmaceuticals division Organon have begun lining up their financial advisers in preparation for the battle ahead.

Bank of America, Citigroup and UBS are understood to be advising The Blackstone Group, Apax Partners, Bain Capital and Texas Pacific Group.